Marburgvirus

"Marburgvirus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A genus in the family FILOVIRIDAE consisting of one species (Lake Victoria marburgvirus) with several strains. The genus shows no antigenic cross-reactivity with EBOLAVIRUS.

Descriptor ID

D029024

MeSH Number(s)

B04.820.455.300.650

B04.909.777.455.300.650

Concept/Terms

Marburgvirus

Lake Victoria marburgvirus

Below are MeSH descriptors whose meaning is more general than "Marburgvirus".

Organisms [B]
Viruses [B04]
RNA Viruses [B04.820]
Mononegavirales [B04.820.455]
Filoviridae [B04.820.455.300]
Marburgvirus [B04.820.455.300.650]
Vertebrate Viruses [B04.909]
RNA Viruses [B04.909.777]
Mononegavirales [B04.909.777.455]
Filoviridae [B04.909.777.455.300]
Marburgvirus [B04.909.777.455.300.650]

Below are MeSH descriptors whose meaning is related to "Marburgvirus".

Below are MeSH descriptors whose meaning is more specific than "Marburgvirus".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Marburgvirus" by people in Harvard Catalyst Profiles by year, and whether "Marburgvirus" was a major or minor topic of these publication.

Bar chart showing 13 publications over 8 distinct years, with a maximum of 3 publications in 2011 and 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2006	1	0	1
2010	1	1	2
2011	1	2	3
2016	1	0	1
2018	1	0	1
2019	1	0	1
2020	1	2	3
2022	1	0	1

Below are the most recent publications written about "Marburgvirus" by people in Profiles.

A platform trial design for preventive vaccines against Marburg virus and other emerging infectious disease threats. Clin Trials. 2022 12; 19(6):647-654.

View in: PubMed
Marburg virus disease: A summary for clinicians. Int J Infect Dis. 2020 Oct; 99:233-242.

View in: PubMed
Non-neutralizing Antibodies from a Marburg Infection Survivor Mediate Protection by Fc-Effector Functions and by Enhancing Efficacy of Other Antibodies. Cell Host Microbe. 2020 06 10; 27(6):976-991.e11.

View in: PubMed
Structure-Based Design of Prefusion-Stabilized Filovirus Glycoprotein Trimers. Cell Rep. 2020 03 31; 30(13):4540-4550.e3.

View in: PubMed
Host and Viral Proteins Modulating Ebola and Marburg Virus Egress. Viruses. 2019 01 03; 11(1).

View in: PubMed
The Marburgvirus-Neutralizing Human Monoclonal Antibody MR191 Targets a Conserved Site to Block Virus Receptor Binding. Cell Host Microbe. 2018 Jan 10; 23(1):101-109.e4.

View in: PubMed
Ebola research funding: a systematic analysis, 1997-2015. J Glob Health. 2016 Dec; 6(2):020703.

View in: PubMed
Mapping the zoonotic niche of Marburg virus disease in Africa. Trans R Soc Trop Med Hyg. 2015 Jun; 109(6):366-78.

View in: PubMed
Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primates. PLoS Negl Trop Dis. 2012; 6(3):e1567.

View in: PubMed
Filoviruses require endosomal cysteine proteases for entry but exhibit distinct protease preferences. J Virol. 2012 Mar; 86(6):3284-92.

View in: PubMed

Related Networks

People

Explore

Similar Concepts

Top Journals

J Virol
Cell Host Microbe
Trans R Soc Trop Med Hyg
PLoS Negl Trop Dis
J Infect Dis
J Glob Health
J Gen Virol
J Biol Chem
Clin Trials
Cell